Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. Lenalidomide and Gemcitabine (Dose level 11)

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Peripheral T-cell Lymphomas (PTCL)

   phase 2 · small molecule · terminated

   1 trial →

2. Lenalidomide combined with G-CHOP (LO CHOP)

   The First People's Hospital of Lianyungang

   DLBCL - Diffuse Large B Cell Lymphoma

   phase 2 · small molecule · active

   1 trial →

3. Lenvatinib

   Eisai Co.,

   Osteosarcoma

   phase 2 · small molecule · completed

   1 trial →

4. Lenvatinib

   United Therapeutics Europe Ltd

   Columnar Cell Variant Thyroid Gland Papillary Carcinoma

   phase 2 · small molecule · completed

   1 trial →

5. Lenvatinib

   The First People's Hospital of Lianyungang

   Biliary Tract Cancer

   phase 2 · small molecule · active

   1 trial →

6. Lenvima 4 mg Oral Capsule

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Hepatocellular Carcinoma (HCC)

   phase 2 · small molecule · active

   1 trial →

7. Letrozole

   United Therapeutics Europe Ltd

   Breast Cancer

   phase 2 · small molecule · completed

   1 trial →

8. Letrozole

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Uterine Cervical Neoplasms

   phase 2 · small molecule · active

   1 trial →

9. Leucovorin

   Cardiff Oncology

   Colorectal Cancer

   phase 2 · small molecule · completed

   1 trial →

10. Leukine for Ovarian cancer

    Nordic Bioscience A/S

    Ovarian cancer

    phase 2 · small molecule · active

    1 trial →

11. Leuprolide or goserelin

    NORTHWEST BIOTHERAPEUTICS INC

    Cancer

    phase 2 · small molecule · completed

    1 trial →

12. Leuprorelin

    Takeda

    Prostatic Neoplasms

    phase 2 · small molecule · completed

    1 trial →

13. Levact 2 for Relapsed/refractory large B-cel…

    The George Institute

    Relapsed/refractory large B-cell non-Hodgkin lymphoma, mantle cell lymphoma, and follicular lymphoma

    phase 2 · small molecule · active

    1 trial →

14. Lifileucel

    Iovance Biotherapeutics B.V.

    Melanoma (Skin Cancer)

    phase 2 · mab · active

    1 trial →

15. Lifileucel

    Iovance Biotherapeutics B.V.

    Metastatic Melanoma

    phase 2 · mab · completed

    2 trials →

16. Lifileucel

    Iovance Biotherapeutics B.V.

    Endometrial Cancer

    phase 2 · mab · active

    1 trial →

17. Light-activated AU-011

    Aura Biosciences

    Uveal Melanoma

    phase 2 · small molecule · completed

    1 trial →

18. Linperlisib combination with obinutuzumab

    The First People's Hospital of Lianyungang

    Lymphoma

    phase 2 · small molecule · active

    1 trial →

19. Lintuzumab-Ac225

    Actinium Pharmaceuticals

    Acute Myeloid Leukemia

    phase 2 · mab · active

    2 trials →

20. Liposomal Annamycin

    Moleculin Biotech

    Leukemia, Myeloid, Acute

    phase 2 · small molecule · completed

    3 trials →

21. Liposomal Annamycin (L-Annamycin)

    Moleculin Biotech

    Sarcoma,Soft Tissue

    phase 2 · small molecule · completed

    1 trial →

22. Liposomal Irinotecan

    United Therapeutics Europe Ltd

    Oncology

    phase 2 · small molecule · completed

    1 trial →

23. Liposomal doxorubicin hydrochloride

    Teva Pharma GmbH

    Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

24. Liposomal irinotecan

    The First People's Hospital of Lianyungang

    Pancreatic Ductal Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

25. Liposome-encapsulated Daunorubicin-Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia

    phase 2 · small molecule · active

    2 trials →

26. Liposome-encapsulated Daunorubicin-Cytarabine

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

    phase 2 · small molecule · active

    1 trial →

27. Lipotecan

    Taiwan Liposome Company

    HepatoCellular Carcinoma

    phase 2 · small molecule · terminated

    1 trial →

28. Lisocabtagene maraleucel

    Celgene Europe Limited

    Relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma (NHL)

    phase 2 · small molecule · active

    1 trial →

29. Loncastuximab Tesirine

    ADC Therapeutics SA

    Diffuse Large B-cell Lymphoma

    phase 2 · small molecule · active

    4 trials →

30. Loncastuximab Tesirine

    ADC Therapeutics SA

    Relapsed or Refractory Large B-cell Lymphoma

    phase 2 · small molecule · active

    1 trial →

31. Loncastuximab Tesirine

    ADC Therapeutics SA

    Relapsed Follicular Lymphoma

    phase 2 · small molecule · terminated

    1 trial →

32. Loncastuximab tesirine

    ADC Therapeutics SA

    Diffuse Large B-Cell Lymphoma Refractory

    phase 2 · small molecule · completed

    1 trial →

33. Loncastuximab tesirine

    ADC Therapeutics SA

    Follicular Lymphoma

    phase 2 · small molecule · active

    1 trial →

34. Loncastuximab tesirine 150 µg/Kg

    ADC Therapeutics SA

    Marginal Zone Lymphoma

    phase 2 · small molecule · active

    1 trial →

35. Lonsurf / film-coated tablets for FGFR2b-positive, advanced or me…

    The George Institute

    FGFR2b-positive, advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction

    phase 2 · small molecule · active

    1 trial →

36. Low Molecular Weight Heparin (LMWH)

    Cardiff Oncology

    Cancer

    phase 2 · small molecule · terminated

    1 trial →

37. Low dose FRα vaccine

    Marker Therapeutics

    Breast Cancer

    phase 2 · mab · completed

    1 trial →

38. Low-dose ASA

    Atrium Therapeutics

    Germ Cell Tumor

    phase 2 · small molecule · active

    1 trial →

39. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Advanced Soft-tissue Sarcoma

    phase 2 · small molecule · active

    1 trial →

40. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Small Cell Lung Cancer ( SCLC )

    phase 2 · small molecule · active

    1 trial →

41. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Refractory Ewing Sarcoma

    phase 2 · small molecule · active

    1 trial →

42. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Locally Advanced Soft Tissue Sarcoma

    phase 2 · small molecule · terminated

    1 trial →

43. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Extensive-stage Small-cell Lung Cancer

    phase 2 · small molecule · active

    1 trial →

44. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Ewing Sarcoma

    phase 2 · small molecule · active

    1 trial →

45. Lurbinectedin

    Jazz Pharmaceuticals Ireland Limited

    Advanced Solid Tumor

    phase 2 · small molecule · terminated

    1 trial →

46. Lutetium (177Lu) rhPSMA-10.1 injection

    Blue Earth Diagnostics Ireland Ltd

    Metastatic castration-resistant prostate cancer (mCRPC)

    phase 2 · small molecule · active

    1 trial →

47. Luveltamab tazevibulin

    SUTRO BIOPHARMA, INC.

    Lung Cancer

    phase 2 · small molecule · terminated

    1 trial →

48. Luveltamab tazevibulin

    SUTRO BIOPHARMA, INC.

    Acute Myeloid Leukemia (AML)

    phase 2 · small molecule · terminated

    1 trial →

Frequently asked questions